Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient?

OBJECTIVES--The objectives were to assess (a) the comparative merits of commonly used disease modifying drugs in the treatment of rheumatoid arthritis (RA) and (b) the influence of age, gender, and disease duration on the outcome of treatment. METHODS--Collected analysis (meta-analysis) was performe...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Capell, H A, Porter, D R, Madhok, R, Hunter, J A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1993
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1005066/
https://ncbi.nlm.nih.gov/pubmed/8100702
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak